Autoimmune neuromyotonia following human papilloma virus vaccination.
Chiara
C
Cerami
Massimo
M
Corbo
Giovanni
G
Piccolo
Sandro
S
Iannaccone
D000328:Adult; D001327:Autoimmune Diseases / Q000139:chemically induced*; D053447:Channelopathies / Q000139:chemically induced; D006801:Humans; D007117:Immunization, Secondary / Q000009:adverse effects; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D020386:Isaacs Syndrome / Q000139:chemically induced*; D008279:Magnetic Resonance Imaging; D008297:Male; D018908:Muscle Weakness / Q000139:chemically induced; D053918:Papillomavirus Vaccines / Q000009:adverse effects*; D015221:Potassium Channels / Q000276:immunology / Q000502:physiology; D013952:Thymus Hyperplasia / Q000139:chemically induced / Q000473:pathology; D014057:Tomography, X-Ray Computed
D007166:Immunosuppressive Agents; D053918:Papillomavirus Vaccines; D015221:Potassium Channels